A metamaterial platform solution that ignites change
The EVOQ platform produces uniform sphere metamaterials that integrate into existing manufacturing workflows. Active development in medical devices and therapeutics. Emerging applications across energy, agriculture, and advanced polymers.
An enabling platform technology
EVOQ metamaterials are produced with uniform spherical morphology, consistent size profile, and structural stability. No chemical additives, no capping agents. These properties are engineered at production, making integration straightforward across manufacturing contexts.
EVOQ Bio
Non-ionic, antimicrobial metamaterials are being studied for their potential effects on a range of microorganisms, with ongoing research evaluating their role in minimizing the risk of antimicrobial resistance.
Explore BioEVOQ MedTech
Engineering solutions with stable, integrated metamaterials to support long-lasting device performance and promote safety.
Explore MedTechWhat the data shows
The EVOQ production process yields stable, scalable metamaterials with demonstrated performance in preclinical studies.
In laboratory testing, EVQ-218 showed broad-spectrum antimicrobial activity across 64+ isolates, with no resistance observed after 30 serial passages across six ESKAPE pathogens. Physicochemical characterization is verified against NIST standards and published in ACS Omega.
Preclinical inhalation and device-coating studies support continued development. The platform integrates into existing manufacturing processes without major workflow changes.
Ready to evaluate EVOQ metamaterials for your application?
The EVOQ platform integrates into existing manufacturing processes. Connect with the team to discuss your use case.